Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709602 · ClinicalTrials.gov registry record
SDH of HPV Vaccine Completion
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 3,076
- Enrollment target
NCT03709602 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 3,076 participants.
The verdict
NCT03709602 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 3,076 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adolescents and reduce barriers to receiving the second shot of the vaccine series.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,076 participants |
| Start Date | 2019-01-07 |
| Est. Completion | 2019-12-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03709602
The ClinicalTrials.gov registry entry for NCT03709602 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,076 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03709602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03709602 about?
NCT03709602 is a clinical study titled "SDH of HPV Vaccine Completion". The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adol...
What is the current status of trial NCT03709602?
This trial is currently completed. The enrollment target is 3,076 participants. The study started on 2019-01-07. Estimated completion is 2019-12-17.
Who is sponsoring clinical trial NCT03709602?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.